Finance

Lists
Why is VLA up 3,88%?
Dive Deeper
VLA:EPA
Valneva SE
2,52 €
+3,88%
(+0,094) 1D
20 ოქტ, 17:35:12 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for VLA...
Open
2,43 €
High
2,54 €
Low
2,36 €
Mkt. cap
485,29 მლნ.
Avg. vol.
344,14 ათ.
Volume
720,83 ათ.
52-wk high
5,15 €
52-wk low
2,03 €
EPS
-0,89 €
Shares outstanding
189,77 მლნ.
No. of employees
620
Open
2,43 €
High
2,54 €
Low
2,36 €
Mkt. cap
485,29 მლნ.
Avg. vol.
344,14 ათ.
Volume
720,83 ათ.
52-wk high
5,15 €
52-wk low
2,03 €
EPS
-0,89 €
Shares outstanding
189,77 მლნ.
No. of employees
620
News stories
From web sources and news partners
Profile
Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States. Wikipedia
About Valneva SE
CEOთომას ლინგელბახი
Employees620
Founded2013
Headquarters-
Sector-
Websitevalneva.com
Last report
13 აგვ. 2026
Fiscal period
Q2 2026
-0,17 € / -0,10 €
-80,74%miss
Revenue / Est. (EUR)
34,94 მლნ. / 37,72 მლნ.
-7,39%miss
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
29,41 მლნ.
47,69 მლნ.
30,90 მლნ.
34,94 მლნ.
Cost of goods sold
51,19 მლნ.
61,64 მლნ.
41,40 მლნ.
48,36 მლნ.
Cost of revenue
51,19 მლნ.
61,64 მლნ.
41,40 მლნ.
48,36 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18,80 მლნ.
16,54 მლნ.
15,14 მლნ.
13,77 მლნ.
Operating expense
15,56 მლნ.
13,73 მლნ.
13,20 მლნ.
12,75 მლნ.
Total operating expenses
66,76 მლნ.
75,37 მლნ.
54,60 მლნ.
61,11 მლნ.
Operating income
-37,35 მლნ.
-27,68 მლნ.
-23,70 მლნ.
-26,17 მლნ.
Other non operating income
-37,00 ათ.
-
-
874,00 ათ.
EBT including unusual items
-43,47 მლნ.
-51,08 მლნ.
-31,25 მლნ.
-31,77 მლნ.
EBT excluding unusual items
-43,70 მლნ.
-51,49 მლნ.
-31,25 მლნ.
-31,75 მლნ.
Income tax expense
882,00 ათ.
-1,06 მლნ.
824,00 ათ.
-566,00 ათ.
Effective tax rate
-2,03%
2,08%
-2,64%
1,78%
Other operating expenses
-3,24 მლნ.
-2,81 მლნ.
-1,93 მლნ.
-1,02 მლნ.
Net income
-44,36 მლნ.
-50,02 მლნ.
-32,07 მლნ.
-31,20 მლნ.
Net profit margin
-150,82%
-104,89%
-103,78%
-89,31%
Earnings per share
-
-
-0,18
-0,17
Interest and investment income
845,00 ათ.
-
526,00 ათ.
-
Interest expense
-5,67 მლნ.
-24,71 მლნ.
-5,09 მლნ.
-5,54 მლნ.
Net interest expenses
-4,83 მლნ.
-24,71 მლნ.
-4,57 მლნ.
-5,54 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-31,96 მლნ.
-26,96 მლნ.
-19,46 მლნ.
-21,14 მლნ.
Gain or loss from assets sale
-230,00 ათ.
432,00 ათ.
-
14,00 ათ.
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები